Public Opinion on Legalizing Psychedelics: RAND survey results on psilocybin mushrooms, LSD, and MDMA policy support

Public Opinion on Legalizing Psychedelics uses the 2025 RAND Psychedelics Survey to measure US public support for legalizing psilocybin mushrooms, LSD, and MDMA. Support levels are far lower for psychedelics than for cannabis: 23 percent support legal psilocybin, versus 65 percent for cannabis, while support for legal LSD and MDMA is closer to 10 percent. Among people who have used psilocybin mushrooms, 62 percent support legalization, compared with 80 percent support among cannabis users. Responses also indicate that people want regulated access rather than blanket legalization. The most endorsed supply option for legal psilocybin is use at a medical facility under supervision (49 percent), with fewer endorsing dispensaries (about 28 percent) or personal growing or foraging (23 percent). For reasons, the top motivations for allowing legalization are mental or physical health conditions for psilocybin, LSD, and MDMA.